HR
Insider
Howard W Robin
President & CEOHoward W Robin (President & CEO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Nektar Therapeutics (NKTR). The largest single filing was $1.2M of NKTR (20,000 sh across 4 lots, as filed), executed Jun 16.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.3M
shares × price, as filed
Last traded
Jun 17
Filed Jun 18
Median ADV $69.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
NKTRRecent filings
NKTRSALE
Nektar Therapeutics
View filing →
$1.2M20,000 sh across 4 lots
Exec Jun 16
Filed Jun 18 · 5:30 PM ET NKTRSALE Nektar Therapeutics View filing → $120K
2,207 sh × $54.28
Exec Nov 25 2025
Filed Nov 25 2025 · 5:30 PM ET NKTRSALE Nektar Therapeutics View filing → $102K
2,156 sh × $47.49
Exec Sep 9 2025
Filed Sep 11 2025 · 5:30 PM ET NKTRSALE Nektar Therapeutics View filing → $125K
3,304 sh × $37.87
Exec Sep 5 2025
Filed Sep 8 2025 · 5:30 PM ET